The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Symbicort, 200 micrograms/6 micrograms per inhalation, pressurised inhalation, suspension



AstraZeneca ABPA1019/020/004

Main Information

Trade NameSymbicort, 200 micrograms/6 micrograms per inhalation, pressurised inhalation, suspension
Active SubstancesBudesonide micronised
Formoterol fumarate dihydrate (micronised)
Dosage FormPressurised inhalation, suspension
Licence HolderAstraZeneca AB
Licence NumberPA1019/020/004

Group Information

ATC CodeR03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK07 formoterol and budesonide

Status

License statusAuthorised
Licence Issued22/07/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back